ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Randomized Controlled Trial Of Spironolactone Effect In Kidney Transplant Recipients Of Living Donors

    N. A. Bobadilla1, L. E. Morales-Buenrostro1, J. A. Ortega-Trejo1, R. Perez-Villalva1, L. Marino1, Y. González-Bobadilla1, H. Juarez1, F. Zamora-Mejía1, N. Gonzalez1, R. Espinoza2, J. Barrera-Chimal3

    1Nephrology, INCMNSZ, Mexico City, Mexico, 2Nephrology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico, 3Molecular Physiology Unit, Instituto de Investigaciones Biomédicas, UNAM, Mexico City, Mexico

    *Purpose: Mineralocorticoid receptor antagonism prevents acute kidney injury induced by ischemia/reperfusion in rodent and pig preclinical models. In a pilot study, we showed that spironolactone…
  • 2019 American Transplant Congress

    CD38 Inhibition: A Novel Target for Hepatic Ischemia Reperfusion Injury

    C. Akateh1, B. F. Reader1, Y. Lee1, J. Kim1, K. Maynard1, K. W. Washburn1, J. L. Zweier2, B. A. Whitson1, S. M. Black1

    1Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 2The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: Ischemia/reperfusion injury (IRI) is a major source of injury during many surgical procedures on the liver, and severe IRI can lead to post-hepatectomy liver…
  • 2019 American Transplant Congress

    Improvement of the Outcome of Clinical Islet Transplantation Depending on the Era in Japan

    Y. Akashi1, T. Kenmochi2, T. Ito3, K. Kurihara2, N. Aida2, A. Kawai2, M. Hayashi4, K. Kouketsu4

    1Faculty of Nursing, School of Health Sciences, Fujita Health University, Toyoake, Japan, 2Department of Transplantation and Regenerative Medicine, Fujita Health University, Toyoake, Japan, 31 Department of Transplantation and Regenerative Medicine,, Fujita Health University, Toyoake, Japan, 4Transplant medical support office, Fujita Health University Hospital, Toyoake, Japan

    *Purpose: Islet transplantation (ITX) is an ideal treatment for type 1 diabetic patients. In this paper, we compared the outcome of ITX depending on Era…
  • 2019 American Transplant Congress

    Evaluating Adherence to Immunosuppressive Drugs through Trackyourmed® an Innovative Qr Code-Scanner App in Renal Transplantation: Preliminary Results from i-COM Trial

    E. Melilli1, M. Meneghini1, N. Montero1, A. Coloma1, I. Revuelta2, F. Moreso3, V. Torregrosa2, J. Grinyo1, O. Bestard1

    1Renal Transplant Unit, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain, 2Renal Transplant Unit, Hospital Clinic, Barcelona, Spain, 3Renal Transplant Unit, Vall D'Hebron Hospital, Barcelona, Spain

    *Purpose: Low adherence to chronic immunosuppressive (IS) drugs has been recognized as a major cause of premature graft loss. Although erratic trough blood IS levels…
  • 2019 American Transplant Congress

    Characterization of HLA Antibodies by C3d Assay and IgG Subclasses in Sensitized Kidney Transplant Patients

    A. Casillas-Abundis, J. M. Arreola-Guerra, J. Alberu, M. I. Solis-G, L. Llorente, J. Granados, M. Vilatoba, R. Cruz-Martinez, L. Morales-Buenrostro, A. G. Contreras

    Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico

    *Purpose: To determine the detection rate of IgG subclasses (IgGsc) and C3d-binding HLA-antibodies (abs) in a cohort of highly sensitized kidney transplant patients.*Methods: We evaluated,…
  • 2019 American Transplant Congress

    Non-Invasive Monitoring of the Kidney Allograft

    S. Bontha1, G. Darville1, C. Kuscu1, C. Kuscu2, A. Bajwa1, J. Eason3, D. Maluf4, V. Mas5

    1Surgery, UTHSC, Memphis, TN, 2Surgery, UTHSC, memphis, TN, 3Surgery, Director of Transplant Institute - UTHSC, Memphis, TN, 4UTHSC, Memphis, TN, 5Surgery, Director of Transplant Research Institute, Memphis, TN

    *Purpose: A major issue in kidney transplantation is the lack of validated non-invasive biomarkers for monitoring graft function, current biochemical markers (i.e., creatinine) have poor…
  • 2019 American Transplant Congress

    Validation of Gene Expression Signatures Associated with Antibody-Mediated Rejection (ABMR) in Renal Allograft Biopsies (Bx) of HLA-Sensitized Patients

    H. Zhang1, C. C. Nast2, N. Ammerman3, A. A. Vo3, S. C. Jordan3, M. Toyoda1

    1Transplant Immunology Laboratory, Cedars-Sinai Medical Center, Los Angeles, CA, 2Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 3Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: "Thoroughly validated gene transcripts” in renal Bx was adopted as one of the criteria for ABMR diagnosis in the latest Banff classification. Previously, we…
  • 2019 American Transplant Congress

    Predicting Kidney Discards with Donor Admission Text

    A. Placona, C. Martinez, B. Carrico

    United Network for Organ Sharing, Richmond, VA

    *Purpose: Kidney discard rates have increased in part due to technological advancements and deceased donor policy updates that allow for recovery of organs at increased…
  • 2019 American Transplant Congress

    Effect of Human Leukocytic Antigen Matching on Clinical Outcomes after Deceased Donor Renal Allograft Transplant: A Single Centre Experience

    M. E. Gramlick1, M. K. Heer2, S. Yausis2, P. R. Trevillian2

    1Department of Surgery, John Hunter Hospital, Newcastle, Australia, 2Newcastle Transplant Unit, John Hunter Hospital, Newcastle, Australia

    *Purpose: Human leucocyte antigen (HLA) matching has been the cornerstone of kidney allocation policies. With increasing expertise in assessing and managing immunological risks, the impact…
  • 2019 American Transplant Congress

    Long Term Outcomes in Kidney Transplant Recipients Receiving Everolimus (EVR) or Mycophenolate (MPS) in Combination with Tacrolimus (TAC)

    K. Ficher, C. Rosso Felipe, Y. Cardoso Dreige, K. Linhares, A. Ferreira Brígido, S. Stopa, L. Viana, M. Cristelli, P. Gessolo Lins, W. Aguiar, H. Proença, R. Marco, M. Gerbase de Lima, H. Tedesco Silva Junior, J. Medina Pestana

    Hospital do Rim, Nephrology Division, EPM - UNIFESP, São Paulo, Brazil

    *Purpose: Detailed long-term data comparing the use of EVR or MPS in kidney transplant recipients receiving TAC is lacking.*Methods: This is a 5-years extension analysis…
  • « Previous Page
  • 1
  • …
  • 190
  • 191
  • 192
  • 193
  • 194
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences